23andMe Holding Co. (ME) NASDAQ
$2.22 0.03 (1.37%)
Market Cap: $632.35M
As of 03/24/23 03:11 PM EDT. Market open.
23andMe Holding Co. (ME)
NASDAQ
$2.22
0.03 (1.37%)
Market Cap: $632.35M
As of 03/24/23 03:11 PM EDT. Market open.
23andMe, Inc., headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple FDA clearances for genetic health reports. The company has created the world’s largest ... read more
23andMe, Inc., headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple FDA clearances for genetic health reports. The company has created the world’s largest crowdsourced platform for genetic research, with 80% of its customers electing to participate. The 23andMe research platform has generated more than 180 publications on the genetic underpinnings of a wide range of diseases. The platform also powers the 23andMe Therapeutics group, currently pursuing drug discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory, and cardiovascular diseases, in addition to other therapeutic areas. read less
Open in: 
Open in:
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Hillan Kenneth J. | Chief Therapeutics Officer | Feb 20, 2023 | Option Exercise | $2.87 | 5,457 | 15,662 | 191,705 | Feb 22, 2023, 05:12 PM |
| Selsavage Joseph Anthony | Interim CFO | Feb 20, 2023 | Option Exercise | $2.87 | 7,321 | 21,011 | 269,957 | Feb 22, 2023, 05:11 PM |
| HIBBS KATHY L | Chief Administrative Officer | Feb 20, 2023 | Option Exercise | $2.87 | 5,457 | 15,662 | 230,372 | Feb 22, 2023, 05:10 PM |
| HIBBS KATHY L | Chief Administrative Officer | Dec 05, 2022 | Sale | $3.25 | 26,259 | 85,342 | 235,829 | Dec 06, 2022, 05:44 PM |
| Selsavage Joseph Anthony | Interim CFO | Nov 20, 2022 | Option Exercise | $2.99 | 10,105 | 30,214 | 277,278 | Nov 22, 2022, 04:14 PM |
| HIBBS KATHY L | Chief Administrative Officer | Nov 20, 2022 | Option Exercise | $2.99 | 4,628 | 13,838 | 262,088 | Nov 22, 2022, 04:12 PM |
| Hillan Kenneth J. | Chief Therapeutics Officer | Nov 20, 2022 | Option Exercise | $2.99 | 4,628 | 13,838 | 197,162 | Nov 22, 2022, 04:11 PM |
| SCHELLER RICHARD H | Director | Nov 11, 2022 | Sale | $3.24 | 18,421 | 59,684 | 72,388 | Nov 14, 2022, 04:38 PM |
| BOTHA ROELOF | Director | Sep 06, 2022 | Option Exercise | $3.08 | 3,251 | 10,013 | 110,561 | Sep 08, 2022, 04:46 PM |
| Chung Patrick S | Director | Sep 06, 2022 | Option Exercise | $3.08 | 3,414 | 10,515 | 113,034 | Sep 08, 2022, 04:45 PM |
| Hernandez Sandra R MD | Director | Sep 06, 2022 | Option Exercise | $3.08 | 3,251 | 10,013 | 143,186 | Sep 08, 2022, 04:42 PM |
| MONTGOMERY RICE VALERIE MD | Director | Sep 06, 2022 | Option Exercise | $3.08 | 3,577 | 11,017 | 149,049 | Sep 08, 2022, 04:41 PM |
| Hernandez Sandra R MD | Director | Aug 25, 2022 | Option Exercise | $3.03 | 13,201 | 39,999 | 125,302 | Aug 29, 2022, 04:33 PM |
| MONTGOMERY RICE VALERIE MD | Director | Aug 25, 2022 | Option Exercise | $3.03 | 17,821 | 53,998 | 130,839 | Aug 29, 2022, 04:32 PM |
| Chung Patrick S | Director | Aug 25, 2022 | Option Exercise | $3.03 | 18,811 | 56,997 | 94,987 | Aug 29, 2022, 04:31 PM |
| BOTHA ROELOF | Director | Aug 25, 2022 | Option Exercise | $3.03 | 16,501 | 49,998 | 92,677 | Aug 29, 2022, 04:30 PM |
| Hillan Kenneth J. | Chief Therapeutics Officer | Aug 24, 2022 | Sale | $3.64 | 8,753 | 31,861 | 196,083 | Aug 25, 2022, 05:00 PM |
| Schoch Steven J | Chief Financial Officer | Aug 20, 2022 | Option Exercise | $3.33 | 4,782 | 15,924 | 211,663 | Aug 22, 2022, 06:12 PM |
| Hillan Kenneth J. | Chief Therapeutics Officer | Aug 20, 2022 | Option Exercise | $3.33 | 4,628 | 15,411 | 204,836 | Aug 22, 2022, 06:12 PM |
| HIBBS KATHY L | Chief Administrative Officer | Aug 20, 2022 | Option Exercise | $3.33 | 4,628 | 15,411 | 263,636 | Aug 22, 2022, 06:11 PM |
| Schoch Steven J | Chief Financial Officer | Jun 01, 2022 | Option Exercise | $2.82 | 4,782 | 13,485 | 216,445 | Jun 02, 2022, 04:28 PM |
| Hillan Kenneth J. | Chief Therapeutics Officer | Jun 01, 2022 | Option Exercise | $2.82 | 4,627 | 13,048 | 209,464 | Jun 02, 2022, 04:26 PM |
| HIBBS KATHY L | Chief Administrative Officer | Jun 01, 2022 | Option Exercise | $2.82 | 4,627 | 13,048 | 268,264 | Jun 02, 2022, 04:25 PM |
| Lovell Evan | Director | Mar 10, 2022 | Buy | $4.41 | 11,467 | 50,558 | 11,467 | Mar 11, 2022, 04:05 PM |
| HIBBS KATHY L | Chief Legal Officer | Jan 06, 2022 | Option Exercise | $0.42 | 58,800 | 24,696 | 58,800 | Jan 07, 2022, 04:11 PM |
| Lemon Steven | Vice President, Engineering | Jan 05, 2022 | Option Exercise | $0.23 | 127,647 | 29,359 | 127,647 | Jan 07, 2022, 04:08 PM |
| BROWN DOUGLAS R | Director | Oct 06, 2020 | Buy | $10.00 | 100,000 | 1,000,000 | 100,000 | Oct 08, 2020, 08:22 PM |
| Owner | Relationship | Date | Value($) |
| Hillan Kenneth J. | Chief Therapeutics Officer | 02/20/2023 | 15,662 |
| Selsavage Joseph Anthony | Interim CFO | 02/20/2023 | 21,011 |
| HIBBS KATHY L | Chief Administrative Officer | 02/20/2023 | 15,662 |
| HIBBS KATHY L | Chief Administrative Officer | 12/05/2022 | 85,342 |
| Selsavage Joseph Anthony | Interim CFO | 11/20/2022 | 30,214 |
| HIBBS KATHY L | Chief Administrative Officer | 11/20/2022 | 13,838 |
| Hillan Kenneth J. | Chief Therapeutics Officer | 11/20/2022 | 13,838 |
| SCHELLER RICHARD H | Director | 11/11/2022 | 59,684 |
| BOTHA ROELOF | Director | 09/06/2022 | 10,013 |
| Chung Patrick S | Director | 09/06/2022 | 10,515 |
| Hernandez Sandra R MD | Director | 09/06/2022 | 10,013 |
| MONTGOMERY RICE VALERIE MD | Director | 09/06/2022 | 11,017 |
| Hernandez Sandra R MD | Director | 08/25/2022 | 39,999 |
| MONTGOMERY RICE VALERIE MD | Director | 08/25/2022 | 53,998 |
| Chung Patrick S | Director | 08/25/2022 | 56,997 |
| BOTHA ROELOF | Director | 08/25/2022 | 49,998 |
| Hillan Kenneth J. | Chief Therapeutics Officer | 08/24/2022 | 31,861 |
| Schoch Steven J | Chief Financial Officer | 08/20/2022 | 15,924 |
| Hillan Kenneth J. | Chief Therapeutics Officer | 08/20/2022 | 15,411 |
| HIBBS KATHY L | Chief Administrative Officer | 08/20/2022 | 15,411 |
| Schoch Steven J | Chief Financial Officer | 06/01/2022 | 13,485 |
| Hillan Kenneth J. | Chief Therapeutics Officer | 06/01/2022 | 13,048 |
| HIBBS KATHY L | Chief Administrative Officer | 06/01/2022 | 13,048 |
| Lovell Evan | Director | 03/10/2022 | 50,558 |
| HIBBS KATHY L | Chief Legal Officer | 01/06/2022 | 24,696 |
| Lemon Steven | Vice President, Engineering | 01/05/2022 | 29,359 |
| BROWN DOUGLAS R | Director | 10/06/2020 | 1,000,000 |
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 18,262,355 | 0.00124% | 13.42% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 5,052,912 | 0.00153% | 9.17% | Other |
| ALTIMETER CAPITAL MANAGEMENT, LP | 1,652,021 | 0.1% | Exited | Growth |
| RENAISSANCE TECHNOLOGIES LLC | 616,900 | 0.00182% | -48.9% | Other |
| DRAGONEER INVESTMENT GROUP, LLC | 500,000 | 0.03% | No change | Growth |
| SCULPTOR CAPITAL LP | 255,000 (Put) | 0.00961% | No change | Event Driven |
| SCULPTOR CAPITAL LP | 255,000 | 0.00961% | No change | Event Driven |
| TUDOR INVESTMENT CORP ET AL | 72,700 | 0.0031% | -47.32% | Event Driven, Other |
| ALPINE GLOBAL MANAGEMENT, LLC | 50,212 | 0.04% | New | Event Driven |
| GREENLIGHT CAPITAL INC | 23,591 | 0.00353% | No change | Activists |
| MILLER VALUE PARTNERS, LLC | 10,000 | 0.00176% | Exited | Value |
Period of Report: 12/31/2022
10-K/10-Q Filings: View